Navigation Links
Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
Date:6/17/2008

New Data Highlights the Need for Testosterone Screening in At-Risk

Hypogonadal Men

BEDMINSTER, N.J., June 17 /PRNewswire/ -- New data from a 12-month, international, multi-center study showed that treatment for low testosterone with Tostran(R), a topical, metered dose 2% testosterone gel, significantly improves insulin sensitivity and sexual function among hypogonadal men with Type 2 diabetes and/or Metabolic Syndrome. These data were presented today at the Endocrine Society's 90th Annual Meeting in San Francisco. Tostran, also marketed as Fortigel, Tostrex and Itnogen, is available in 13 countries across Europe, and ProStrakan (LSE: PSK), an international specialty pharmaceutical company, plans to file Tostran with U.S. regulatory authorities later this year.

The Testosterone replacement In hypogonadal men with either MEtabolic Syndrome or type 2 diabetes (TIMES 2) study looked at the effects of Tostran on insulin resistance, diabetic control, lipids, quality of life and symptoms of hypogonadism. The placebo-controlled study of 220 hypogonadal men met its primary endpoint by showing a statistically significant improvement in insulin sensitivity in testosterone treated patients at six and 12 months (p=0.05 and p=0.01, respectively), as measured by homeostasis model assessment as an index of insulin resistance (HOMA-IR). Further, measured by the Index of Erectile Function (IIEF), patients using the testosterone gel saw significant improvement in sexual function at six and 12 months (p <0.05).

"These data tell us that replacement therapy for low testosterone in hypogonadal males not only improves sexual function but, more importantly, can also have impact on insulin sensitivity," said lead investigator T. Hugh Jones BSc, MD, FRCP, Consultant Physician & Endocrinologist and Hon. Professor of Andrology, Barnsley Hospital and University of Sheffield, UK. "The TIMES 2 study indicates for the first time the role
'/>"/>

SOURCE ProStrakan
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
2. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
3. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
4. New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
5. BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer
6. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
7. deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer
8. Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
9. Cytopia Announces Novel Anti-Cancer Drug Development Collaboration
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Latest Cell Publication Describes the Novel Kinase Regulators Using OriGenes Functional Kinome Collection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... NEWTOWN, Pa. , July 6, 2015 /PRNewswire/ ... services and technology provider, today announced that it ... retention firm, MediciGroup ® , Inc. (Medici).  The ... Access to Patients, LLC.  Medici also provides a ... finds missing patients globally.  Together with Medici, ...
(Date:7/6/2015)... , July 6, 2015 Hologic, Inc. (NASDAQ: ... to release its financial results for the third quarter ... the market closes.  In conjunction with the release, management ... p.m. Eastern Time. Interested participants may listen ... the United States ) or 719-325-4804 (for international ...
(Date:7/6/2015)... N.J. and FARMINGTON, Conn. ... Inc. (NYSE MKT: PTN), a biopharmaceutical company developing ... diseases with significant unmet medical need and commercial ... a private placement of Series E warrants to ... Series F warrants to purchase 2,191,781 shares of ...
Breaking Medicine Technology:BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5
... Inc. (RLI), a wholly owned subsidiary of Ranbaxy Laboratories ... and Drug Administration (FDA) has approved Absorica™, a novel, ... the treatment of severe recalcitrant nodular acne. Through a ... RLI is expected to launch Absorica™ in the U.S. ...
... 2012  Janssen Therapeutics, Division of Janssen Products, LP, ... (FDA) has issued a Complete Response letter for ... 800mg tablet of PREZISTA® (darunavir). PREZISTA is ... 400mg tablets -- for the treatment of human immunodeficiency ...
Cached Medicine Technology:Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA 2FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 2FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 3FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 4FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 5FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 6FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 7
(Date:7/6/2015)... ... July 06, 2015 , ... ... Spa industries, announces the return of its complimentary educational webinar series ... medical business leaders creates success for their clients through targeted marketing, sales, digital ...
(Date:7/6/2015)... ... 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a ... at a CAGR of over 3.2 percent in the years to come to hit ... mainly spurred by an anticipated launch of a number of promising pipeline candidates and ...
(Date:7/6/2015)... ... , ... doTERRA, the leading global essential oils company, is pleased to announce ... the position as Director of the Hinckley Institute at the University of Utah, a ... Jowers states that he was ready for a new challenge, and out of many ...
(Date:7/6/2015)... ... ... Seedstock today announced Pierre Sleiman, founder and CEO of Go Green ... Conference – “Innovation and the Small Farmer” – to be held Nov. 3-4 San ... will explore solutions and methodologies that small farmers and entrepreneurs are developing to improve ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... MD Now, ... Monday, July 6. The newly constructed urgent care center will serve residents and visitors ... In addition to being MD Now’s 22nd South Florida location, the new facility will ...
Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3
... new research, Atkins diet-low carbohydrate diet can increase the risks ... the production of a fatty acid in the gut , ... acid butyrate, which protects against colorectal cancer, is produced by ... Rowett Research Institute, in Aberdeen, found that the widely ...
... the rule themselves - and certainly so when it comes ... local authorities have sent notices to the Delhi High Court, ... for breeding mosquitoes, the carrier of the dreaded dengue and ... field visits they have found mosquito breeding grounds in the ...
... launching Stop AIDS in Children, a campaign that calls for ... half a million new infant HIV infections that occur worldwide ... the leaders of the world's eight most powerful countries had ... for prevention of mother-to-child transmission (PMTCT) services in the developing ...
... The British government took a step Wednesday toward offering vaccinations ... a measure that could be carried out by late next ... recommended the use of vaccines to guard against the human ... cases of cervical cancer. ,The Department of Health ...
... her current rehab stint pretty 'serious' and doesn't want to 'mess ... Girls' star said that the actress will be in the rehab ... time frame for her stay due to her work schedule. ... We don't know how much longer because of her work schedule, ...
... dozens of nurses who had blocked a main road in front ... The nurses had set up camp in the street in ... ,An AFP reporter saw several units of police in ... security forces cleared the street itself, the nurses managed to continue ...
Cached Medicine News:Health News:Notice Sent to Courts Asking Them to Stop Courting Mosquitoes 2Health News:AIDS Charity AVERT Launches Stop AIDS in Children Campaign 2Health News:Girls Could Be Vaccinated Against Cervical Cancer in Britain 2Health News:Polish Police Break Up Nurses' Pay Protest 2
Inquire...
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
Inquire...
Medicine Products: